07 August 2025 : Database Analysis
Trends and Efficacy in Clostridioides difficile Infection Management at a Polish Clinical Hospital
Jarosław Drobnik
ABDEG 1, Piotr Pobrotyn ADEFG 2*, Urszula Grata-Borkowska DF 1, Katarzyna Madziarska DE 3, Mateusz Baran ABCDEF 4
DOI: 10.12659/MSM.948254
Med Sci Monit 2025; 31:e948254
Table 3 Analysis of the treatment of hospitalized patients with CDI at the UCHW in 2016–2018 by patient survival.
| Method of treatment (%) | The patients survived | The patients died | P |
|---|---|---|---|
| No chemotherapeutic | 8 (2.53) | 2 (2.56) | |
| Metronidazole only | 73 (23.10) | 12 (15.38) | |
| Vancomycin only | 52 (16.46) | 13 (16.67) | |
| Metronidazole and vancomycin | 83 (26.27) | 45 (57.69) | |
| Rifaximin plus metronidazole and/or vancomycin | 17 (5.38) | 6 (7.69) | |
| Fidaxomicin plus vancomycin or fidaxomicin plus vancomycin and metronidazole | 6 (1.58) | 0 (0) |